Andrew Dunn

Andrew Dunn has a diverse and extensive work experience in journalism and reporting. Andrew started their career as a news intern at the Lowell Sun in 2015 and later worked as a national political reporting intern at The Hill in 2016. Andrew then joined The Baltimore Sun as a metro reporting intern, where they published 53 stories and won a Heart Journalism Award for their breaking news coverage of a homicide.

In 2017, Andrew interned at the Tampa Bay Times, where they split their time between the editorial board and metro reporting. Andrew wrote original stories, editorials, and columns, covering a range of topics relevant to Florida news.

In 2018, Andrew served as a digital political breaking news intern at CNN, working with their political breaking news team. Andrew gained experience reporting for CNNPolitics.com, which is the largest news organization globally.

Andrew's next career move was at Industry Dive, where they worked as an associate editor and later as a reporter for BioPharma Dive, a vertical of the business journalism company. During their time there, they wrote and reported stories on the pharmaceutical and biotechnology industries. Andrew also won several awards, including the 2020 Jesse H. Neal Award for best editorial use of data and was a finalist for the 2020 Azbee Awards of Excellence in data journalism. Additionally, they made appearances on live national cable news programs, such as CNBC's "The Exchange," discussing their original reporting on biotech bankruptcy trends.

From 2020 to 2023, Andrew worked at Business Insider as a healthcare reporter, where they covered various healthcare topics. Andrew then transitioned to the role of senior healthcare reporter before leaving the company.

Currently, Andrew is employed as a biopharma correspondent at Endpoints News, starting in 2023.

Andrew Dunn earned a Bachelor's Degree in Journalism and Economics from the University of Maryland. No specific start or end year was mentioned.